TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15654663

Group type: EXPERIMENTAL
Intervention: Rectus sheath relaxation incisions
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional mass closure
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study: 12680814

Group type: EXPERIMENTAL
Intervention: Audio-only presentation
Number of subjects: 29

Group type: COMPARATOR
Intervention: Audiovisual presentation
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Story-retelling task
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Responses to direct questions
Number of subjects: 29
Study: 10571362

Group type: EXPERIMENTAL
Intervention: Central corneal thickness measurement
Number of subjects: 896
Study: 8964274

Group type: EXPERIMENTAL
Intervention: Felbamate monotherapy
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Chronic open FBM
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Baseline insomnia and anxiety
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Restarting original AEDs
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 1845173

Group type: EXPERIMENTAL
Intervention: Surgeon- and dentist-delivered smoking cessation intervention
Number of subjects: 186
Study: 6614410

Group type: EXPERIMENTAL
Intervention: 10 mg/kg cimetidine orally 120 to 180 minutes prior to induction of anaesthesia
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 40 mg/kg cimetidine rectally in small children up to 15 kg
Number of subjects: 150

Group type: COMPARATOR
Intervention: No prophylaxis
Number of subjects: 150
Study: 30411239

Group type: EXPERIMENTAL
Intervention: Finding My Way (FMW) intervention
Number of subjects: 191

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 191
Study: 29710870

Group type: EXPERIMENTAL
Intervention: High-Carbohydrate Diet (HCD)
Number of subjects: 8

Group type: COMPARATOR
Intervention: High-Fat Diet (HFD)
Number of subjects: 8
Study: 25248661

Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation
Number of subjects: 84

Group type: COMPARATOR
Intervention: Standard orthopedic nursing care (Control)
Number of subjects: 84
Study: 24441952

Group type: EXPERIMENTAL
Intervention: Multifocal IOL (both refractive and diffractive)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Monofocal IOL
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Multifocal IOL
Number of subjects: 21
Study: 22293042

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive behavioral intervention (3 sessions of 90 minutes each)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Wait-list control (2 months)
Number of subjects: 31
Study: 21157170

Group type: EXPERIMENTAL
Intervention: Moxibustion (once a day for 15 min, at least 5 days a week for 8 weeks)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control (no moxibustion treatment)
Number of subjects: 26
Study: 17532336

Group type: COMPARATOR
Intervention: Cabrera's sign (notching in the ascending limb of the S wave in lead V(3), V(4), or V(5))
Number of subjects: 107

Group type: COMPARATOR
Intervention: Chapman's sign (notching of the R wave in lead I, aVL, or V(6))
Number of subjects: 107

Group type: COMPARATOR
Intervention: Presence of a qR in lead I, aVL, or V(6)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Notching of QRS in lead II, III, or aVF
Number of subjects: 107

Group type: COMPARATOR
Intervention: Presence of a qR in lead II, III, or aVF
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: All 5 ECG signs combined
Number of subjects: 107
Study: 16386621

Group type: EXPERIMENTAL
Intervention: Intravenous ganciclovir for the first 21 days
Number of subjects: 25

Group type: COMPARATOR
Intervention: Intravenous ganciclovir followed by oral ganciclovir up to day 120 posttransplantation (historical control group)
Number of subjects: 25
Study: 12011822

Group type: EXPERIMENTAL
Intervention: Acenocoumarol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10348929

Group type: EXPERIMENTAL
Intervention: Highly selective inhibitors of cyclooxygenase-2 (COX-2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Classical NSAIDs (non-selective)
Number of subjects: 0
Study: 8523145

Group type: EXPERIMENTAL
Intervention: Systematic analysis of theories related to aggression
Number of subjects: 0
Study: 2279802

Group type: EXPERIMENTAL
Intervention: Ibuprofen (7 mg/kg)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Paracetamol (8 mg/kg)
Number of subjects: 175
Study: 7247696

Group type: EXPERIMENTAL
Intervention: Cimetidine (200 mg i.v. infusion)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (equal volume and infusion speed)
Number of subjects: 8
Study: 31491873

Group type: EXPERIMENTAL
Intervention: Phytosterol emulsion (1.5 g/day phytosterol equivalents)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 28322987

Group type: EXPERIMENTAL
Intervention: High reward condition
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard reward condition
Number of subjects: 60
Study: 27339303

Group type: EXPERIMENTAL
Intervention: Hydroxyurea
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 25466242

Group type: EXPERIMENTAL
Intervention: Eplerenone (50 mg/day)
Number of subjects: 336

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 336
Study: 22326642

Group type: EXPERIMENTAL
Intervention: HBV-ISS (2 doses at 0 and 4 weeks)
Number of subjects: 2415

Group type: COMPARATOR
Intervention: HBV-Eng (3 doses at 0, 4, and 24 weeks)
Number of subjects: 2415
Study: 19497643

Group type: EXPERIMENTAL
Intervention: Educational magazine (twice monthly)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Standard health intervention (Control group)
Number of subjects: 450
Study: 17251874

Group type: EXPERIMENTAL
Intervention: Genistein (54 mg/d)
Number of subjects: 389

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 389
Study: 14992907

Group type: EXPERIMENTAL
Intervention: Biocompatible perfusion system (n = 19)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional perfusion system (n = 21)
Number of subjects: 40
Study: 11355409

Group type: EXPERIMENTAL
Intervention: Newly designed primer pairs for STR typing (HUMFES, HUMTH01, HUMTPOX)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Commonly used primer pairs for STR typing
Number of subjects: 0
Study: 9300992

Group type: EXPERIMENTAL
Intervention: Echo tracking of digitized radiofrequency ultrasound
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: B-mode imaging with automated edge detection
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: M-mode imaging with automated edge detection
Number of subjects: 26

Group type: COMPARATOR
Intervention: Echo tracking
Number of subjects: 26

Group type: COMPARATOR
Intervention: B-mode imaging
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Fourier series model and cubic smoothing spline
Number of subjects: 26
Study: 8064171

Group type: EXPERIMENTAL
Intervention: Garlic preparation (Kwai)
Number of subjects: 415

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 415
Study: 3120557

Group type: COMPARATOR
Intervention: Terfenadine alone
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Terfenadine associated with cytoprotective drugs (pirenzepine or rosaprostol)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Terfenadine associated with anti-H2 receptor antagonists (ranitidine or famotidine)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Blind placebo
Number of subjects: 105
Study: 29325663

Group type: EXPERIMENTAL
Intervention: Smartphone self-monitoring during a 6-month weight loss trial
Number of subjects: 31
Study: 27120502

Group type: EXPERIMENTAL
Intervention: Adapted patient adherence intervention
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Motivational interview-based provider intervention
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 132
Study: 25636808

Group type: EXPERIMENTAL
Intervention: Mediterranean Diet (MD) adherence intervention including personalized dietary‐nutritional education, Web 2.0 approach, and group sessions for 2 years.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual diet with general nutritional counselling (Control group).
Number of subjects: 0
Study: 23040886

Group type: EXPERIMENTAL
Intervention: Leukotriene D4 (LTD4)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Methacholine
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Both tests (LTD4 and methacholine)
Number of subjects: 83
Study: 21108739

Group type: EXPERIMENTAL
Intervention: TeleMedicine intervention
Number of subjects: 17

Group type: COMPARATOR
Intervention: Physician visit (Control)
Number of subjects: 17
Study: 18349597

Group type: COMPARATOR
Intervention: Mesotherapy (mixed solution of aminophylline, buflomedil, and lidocaine) injected weekly into the superficial dermis of one thigh for 12 weeks.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Mesotherapy (mixed solution of aminophylline, buflomedil, and lidocaine)
Number of subjects: 20
Study: 12506176

Group type: EXPERIMENTAL
Intervention: Concurrent bolus cisplatin with radiation (arm B)
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Split course of radiation with concurrent infusional fluorouracil and bolus cisplatin (arm C)
Number of subjects: 295

Group type: COMPARATOR
Intervention: Single daily fractionated radiation (arm A, control)
Number of subjects: 295
Study: 9609273

Group type: EXPERIMENTAL
Intervention: Polyglactin 910
Number of subjects: 1780

Group type: COMPARATOR
Intervention: Chromic catgut
Number of subjects: 1780
Study: 8570343

Group type: EXPERIMENTAL
Intervention: Discomfort group (maximum arm-cuff pressure of 280 mmHg)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (maximum arm-cuff pressure of 160 mmHg)
Number of subjects: 46
Study: 2203397

Group type: EXPERIMENTAL
Intervention: Intravenous heparin during streptokinase infusion (group 1)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Intravenous heparin after streptokinase infusion (group 2)
Number of subjects: 37
Study: 367716

Group type: EXPERIMENTAL
Intervention: Porcine skin graft
Number of subjects: 28

Group type: COMPARATOR
Intervention: Paraffin gauze (control)
Number of subjects: 28
Study: 31531771

Group type: EXPERIMENTAL
Intervention: Single dose of Streptococcus dentisani (n=5)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Daily dose of Streptococcus dentisani for a week (n=6)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Both dosing schedules of Streptococcus dentisani
Number of subjects: 11
Study: 31064263

Group type: EXPERIMENTAL
Intervention: Information given in labour only, written format
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Information in labour, verbal
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Information at 36 weeks plus labour, written
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Information at 36 weeks plus labour, verbal
Number of subjects: 49

Group type: COMPARATOR
Intervention: Information only during labour
Number of subjects: 49
Study: 28093815

Group type: EXPERIMENTAL
Intervention: Nigella sativa oil (NSO) 500 mg twice daily for 4 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 25972454

Group type: EXPERIMENTAL
Intervention: Armodafinil 150 mg/day
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 22886724

Group type: EXPERIMENTAL
Intervention: Low exposure (0.24 T static magnetic stray field and 0.49 T·s(‐1) time‐varying magnetic field)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: High exposure (0.37 T static magnetic stray field and 0.70 T·s(‐1) time‐varying magnetic field)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham exposure
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Tandem task exposure (all conditions)
Number of subjects: 30
Study: 21285160

Group type: EXPERIMENTAL
Intervention: SCIO-469 30 mg IR
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: SCIO-469 60 mg IR
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: SCIO-469 100 mg ER
Number of subjects: 302

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 302
Study: 19965037

Group type: EXPERIMENTAL
Intervention: Mobile telemonitoring
Number of subjects: 137

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 137
Study: 17454917

Group type: EXPERIMENTAL
Intervention: High-risk smoking status
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Female participants
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: High scores of emotional distress
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Current smoking status
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Emotional distress
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Motivational factors
Number of subjects: 217
Study: 14736573

Group type: EXPERIMENTAL
Intervention: Nicotine administered by patch (3.5 mg for low-hostility non-smokers, 21 mg for high-hostility smokers)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Nicotine administered by patch (21 mg)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Behavioral ratings
Number of subjects: 86
Study: 11546969

Group type: EXPERIMENTAL
Intervention: Fiberoptic endoscopic evaluation of swallowing (FEES)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Routine clinical management
Number of subjects: 70
Study: 9771059

Group type: EXPERIMENTAL
Intervention: Prednisolone pre-treatment
Number of subjects: 213

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 213
Study: 7825161

Group type: EXPERIMENTAL
Intervention: Pedicled omentum
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Thoracic muscle transposition (latissimus dorsi, pectoralis major, serratus anterior, trapezius)
Number of subjects: 64
Study: 2971186

Group type: EXPERIMENTAL
Intervention: RU 41740
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30206020

Group type: EXPERIMENTAL
Intervention: Radiotherapy (RT)
Number of subjects: 46
Study: 28688787

Group type: EXPERIMENTAL
Intervention: Individually customized power wheelchairs for 12 months
Number of subjects: 31
Study: 26247543

Group type: EXPERIMENTAL
Intervention: HF‐WBI
Number of subjects: 287
Study: 23860964

Group type: EXPERIMENTAL
Intervention: Mesenchymal stem cells (MSCs) at a dose of 2 × 10(6) cells/kg for each infusion twice a week for 4 weeks, with the option for weekly infusions for an additional 4 weeks if needed.
Number of subjects: 14
Study: 21771568

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (4 mg every 21-28 days)
Number of subjects: 1960

Group type: EXPERIMENTAL
Intervention: Zoledronic acid
Number of subjects: 1960

Group type: COMPARATOR
Intervention: Clodronic acid
Number of subjects: 1960
Study: 19155070

Group type: EXPERIMENTAL
Intervention: Adherence therapy (8 sessions)
Number of subjects: 373
Study: 17200096

Group type: EXPERIMENTAL
Intervention: Body & Soul dietary intervention
Number of subjects: 0
Study: 14722733

Group type: EXPERIMENTAL
Intervention: Idoxifene
Number of subjects: 56

Group type: COMPARATOR
Intervention: Tamoxifen (40 mg/day)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Idoxifene and Tamoxifen
Number of subjects: 56
Study: 11394918

Group type: EXPERIMENTAL
Intervention: Focus on cold pressor pain sensations
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Avoid cold pressor pain sensations
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: High anxiety sensitivity with avoidance instruction
Number of subjects: 60

Group type: COMPARATOR
Intervention: Low anxiety sensitivity
Number of subjects: 60
Study: 9593789

Group type: EXPERIMENTAL
Intervention: Daily chlorambucil
Number of subjects: 1535

Group type: EXPERIMENTAL
Intervention: Intermittent chlorambucil plus prednisone
Number of subjects: 1535

Group type: COMPARATOR
Intervention: No treatment (control group for first trial)
Number of subjects: 1535

Group type: COMPARATOR
Intervention: No treatment (control group for second trial)
Number of subjects: 1535
Study: 8147544

Group type: EXPERIMENTAL
Intervention: Special intervention (n = 293)
Number of subjects: 585

Group type: COMPARATOR
Intervention: Usual medical care (n = 292)
Number of subjects: 585
Study: 3058874

Group type: EXPERIMENTAL
Intervention: 12-week regimen of adjuvant chemotherapy
Number of subjects: 418

Group type: COMPARATOR
Intervention: 36-week regimen of adjuvant chemotherapy
Number of subjects: 418
Study: 30400876

Group type: EXPERIMENTAL
Intervention: STROKE-CARD intervention
Number of subjects: 2160

Group type: COMPARATOR
Intervention: Usual post-stroke patient care (control)
Number of subjects: 2160
Study: 29308522

Group type: EXPERIMENTAL
Intervention: Ibuprofen 300mg, bid for 5 days after scaling and root planing (SRP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group underwent SRP only
Number of subjects: 20
Study: 26094712

Group type: EXPERIMENTAL
Intervention: Patient controlled analgesia (PCA)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Treatment as usual (nurse titrated analgesia)
Number of subjects: 200
Study: 23035844

Group type: EXPERIMENTAL
Intervention: AC952 Aloe vera inner leaf gel powder
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: UP780 Aloe vera inner leaf gel powder standardized with 2% aloesin
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 20707253

Group type: EXPERIMENTAL
Intervention: Acetaminophen 1000 mg plus codeine 60 mg tid for 24 hours (Group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ketorolac 10 mg qid for 24 hours (Group B)
Number of subjects: 60
Study: 18297251

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ketamine-midazolam
Number of subjects: 20
Study: 16488952

Group type: EXPERIMENTAL
Intervention: DS-MMC (deep sclerectomy with intraoperative low dose mitomycin C 0.25 mg/ml for 2 minutes)
Number of subjects: 39

Group type: COMPARATOR
Intervention: DS-noMMC (deep sclerectomy without mitomycin C)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: DS-MMC
Number of subjects: 39

Group type: COMPARATOR
Intervention: DS-noMMC
Number of subjects: 39
Study: 15106284

Group type: EXPERIMENTAL
Intervention: Sodium enoxaparin administered for 10 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional therapy (corticosteroids, vasoactive agents, multivitamins, and anticoagulants)
Number of subjects: 40
Study: 11102254

Group type: EXPERIMENTAL
Intervention: Clopidogrel (300 mg bolus followed by 75 mg per day for 3-12 months) + Aspirin
Number of subjects: 12500

Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 12500

Group type: EXPERIMENTAL
Intervention: Aspirin + Ticlopidine
Number of subjects: 12500

Group type: COMPARATOR
Intervention: Thienopyridines (including Clopidogrel)
Number of subjects: 12500
Study: 9108859

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (NO)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 61
Study: 8258620

Group type: EXPERIMENTAL
Intervention: Local hyperthermia
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 4062333

Group type: EXPERIMENTAL
Intervention: Intralesional triamcinolone acetonide injection
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Topical 0.05% betamethasone dipropionate under occlusion
Number of subjects: 9

Group type: COMPARATOR
Intervention: Emollient under occlusion (Control)
Number of subjects: 9
Study: 29665109

Group type: EXPERIMENTAL
Intervention: Line-of-sight approach
Number of subjects: 110

Group type: COMPARATOR
Intervention: Side approach
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: APPLES mnemonic
Number of subjects: 110
Study: 27068249

Group type: EXPERIMENTAL
Intervention: Total endoscopic ablation
Number of subjects: 36

Group type: COMPARATOR
Intervention: Rate control therapy
Number of subjects: 36
Study: 24816889

Group type: EXPERIMENTAL
Intervention: Whole-body acute resistance exercise
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Upper-body acute resistance exercise
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Lower-body acute resistance exercise
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control period (rest)
Number of subjects: 34
Study: 21752556

Group type: EXPERIMENTAL
Intervention: Seeking Safety (SS)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Women's Health Education (WHE)
Number of subjects: 106
Study: 20149955

Group type: EXPERIMENTAL
Intervention: 12-month group behavioral treatment designed to increase autonomy and self-regulation for weight control
Number of subjects: 239

Group type: COMPARATOR
Intervention: Health education program
Number of subjects: 239
Study: 18855165

Group type: EXPERIMENTAL
Intervention: SPECT using (99m)Tc‐hexamethylpropyleneamine oxime (HMPAO)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: DSC‐MRI with gadobutrol formula
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no objective cognitive impairment)
Number of subjects: 24
Study: 15807215

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided embryo transfer (n = 178)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Routine methods (Control group, n = 152)
Number of subjects: 330
Study: 14671145

Group type: EXPERIMENTAL
Intervention: GnRH antagonist starting on day 1 of stimulation (n = 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: GnRH antagonist starting on day 6 of stimulation (n = 30)
Number of subjects: 60
Study: 11192147

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Budesonide
Number of subjects: 0
Study: 8636452

Group type: EXPERIMENTAL
Intervention: Chlorhexidine diacetate gum (20 mg total daily)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Placebo gum
Number of subjects: 151

Group type: COMPARATOR
Intervention: 0.2% chlorhexidine gluconate mouthwash (40 mg total daily)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Chlorhexidine diacetate gum
Number of subjects: 151

Group type: COMPARATOR
Intervention: 0.2% chlorhexidine gluconate mouthwash
Number of subjects: 151
Study: 1452916

Group type: EXPERIMENTAL
Intervention: Invasive strategy
Number of subjects: 3534

Group type: COMPARATOR
Intervention: Conservative strategy
Number of subjects: 3534
Study: 3909327

Group type: EXPERIMENTAL
Intervention: Aztreonam plus clindamycin
Number of subjects: 73

Group type: COMPARATOR
Intervention: Gentamicin plus clindamycin
Number of subjects: 73
Study: 31136658

Group type: EXPERIMENTAL
Intervention: Wholegrain rye bread (WGR)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Rye bran or wheat aleurone
Number of subjects: 15